Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04609579
Title Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Silicon Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field